Answers are grounded in this paper and cite their sources.
Siderophore−β-lactam conjugates represent a promising strategy to enhance antibiotic efficacy, yet their molecular basis remains incompletely understood. While improved permeability through TonB-dependent transporters is invoked to explain their activity, our results highlight increased penicillin-binding protein (PBP) affinity. Using Pseudomonas aeruginosa penicillin-binding protein 3 as a model, we compared the binding efficiency constant k2/Ks of unconjugated ampicillin, loracarbef, and their siderophore-based conjugate. Siderophore conjugation induced a modest (∼2-fold) increase in potency for ampicillin, but a much larger (∼50-fold) enhancement for loracarbef. Crystallographic analyses revealed a conserved β-lactam binding mode, while showing that siderophore extension at R1 modifies active-site interactions, notably recruiting residues such as Arg489 and modifying H-bonding interactions. Furthermore, in silico modeling suggests possible interactions between the siderophore and the β3−β4 loop residues. These findings support siderophores as both delivery vectors and structural elements able to increase β-lactam inhibitory potency against PBP.
No takes yet. Share an insight, caveat, or question.
Lacasse et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: